Febuxostat Renoprotection in CKD Patients With Asymptomatic Hyperuricemia
- PMID: 27211368
- DOI: 10.1053/j.ajkd.2015.09.034
Febuxostat Renoprotection in CKD Patients With Asymptomatic Hyperuricemia
Comment in
-
In Reply to 'Febuxostat for Asymptomatic Hyperuricemia in CKD' and 'Febuxostat Renoprotection in CKD Patients With Asymptomatic Hyperuricemia'.Am J Kidney Dis. 2016 Jun;67(6):990-1. doi: 10.1053/j.ajkd.2016.04.001. Am J Kidney Dis. 2016. PMID: 27211369 No abstract available.
Comment on
-
Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial.Am J Kidney Dis. 2015 Dec;66(6):945-50. doi: 10.1053/j.ajkd.2015.05.017. Epub 2015 Jul 30. Am J Kidney Dis. 2015. PMID: 26233732 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
